436 related articles for article (PubMed ID: 24683541)
1. Antitumoral activity of snake venom proteins: new trends in cancer therapy.
Calderon LA; Sobrinho JC; Zaqueo KD; de Moura AA; Grabner AN; Mazzi MV; Marcussi S; Nomizo A; Fernandes CF; Zuliani JP; Carvalho BM; da Silva SL; Stábeli RG; Soares AM
Biomed Res Int; 2014; 2014():203639. PubMed ID: 24683541
[TBL] [Abstract][Full Text] [Related]
2. Snake Venom as an Effective Tool Against Colorectal Cancer.
Uzair B; Atlas N; Malik SB; Jamil N; Ojuolape ST; Rehman MU; Khan BA
Protein Pept Lett; 2018; 25(7):626-632. PubMed ID: 29921196
[TBL] [Abstract][Full Text] [Related]
3. Emerging anticancer potential and mechanisms of snake venom toxins: A review.
Guo X; Fu Y; Peng J; Fu Y; Dong S; Ding RB; Qi X; Bao J
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131990. PubMed ID: 38704067
[TBL] [Abstract][Full Text] [Related]
4. Snake venom phospholipases A2: a new class of antitumor agents.
Rodrigues RS; Izidoro LF; de Oliveira RJ; Sampaio SV; Soares AM; Rodrigues VM
Protein Pept Lett; 2009; 16(8):894-8. PubMed ID: 19689415
[TBL] [Abstract][Full Text] [Related]
5. Snake Venoms in Cancer Therapy: Past, Present and Future.
Li L; Huang J; Lin Y
Toxins (Basel); 2018 Aug; 10(9):. PubMed ID: 30158426
[TBL] [Abstract][Full Text] [Related]
6. Snake venom toxins: Potential anticancer therapeutics.
Offor BC; Piater LA
J Appl Toxicol; 2024 May; 44(5):666-685. PubMed ID: 37697914
[TBL] [Abstract][Full Text] [Related]
7. Amplification of Snake Venom Toxicity by Endogenous Signaling Pathways.
Bickler PE
Toxins (Basel); 2020 Jan; 12(2):. PubMed ID: 31979014
[TBL] [Abstract][Full Text] [Related]
8. Snake venom PLA2s inhibitors isolated from Brazilian plants: synthetic and natural molecules.
Carvalho BM; Santos JD; Xavier BM; Almeida JR; Resende LM; Martins W; Marcussi S; Marangoni S; Stábeli RG; Calderon LA; Soares AM; Da Silva SL; Marchi-Salvador DP
Biomed Res Int; 2013; 2013():153045. PubMed ID: 24171158
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of snake venom in cancer therapy: current perspectives.
Vyas VK; Brahmbhatt K; Bhatt H; Parmar U
Asian Pac J Trop Biomed; 2013 Feb; 3(2):156-62. PubMed ID: 23593597
[TBL] [Abstract][Full Text] [Related]
10. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review.
Schönthal AH; Swenson SD; Chen TC; Markland FS
Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Snake Venomics of the Okinawa Habu Pit Viper,
Damm M; Hempel BF; Nalbantsoy A; Süssmuth RD
Molecules; 2018 Jul; 23(8):. PubMed ID: 30060607
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A
Bryan-Quirós W; Fernández J; Gutiérrez JM; Lewin MR; Lomonte B
Toxicon; 2019 Jan; 157():1-7. PubMed ID: 30447275
[TBL] [Abstract][Full Text] [Related]
13. Cloning and identification of a complete cDNA coding for a bactericidal and antitumoral acidic phospholipase A2 from Bothrops jararacussu venom.
Roberto PG; Kashima S; Marcussi S; Pereira JO; Astolfi-Filho S; Nomizo A; Giglio JR; Fontes MR; Soares AM; França SC
Protein J; 2004 May; 23(4):273-85. PubMed ID: 15214498
[TBL] [Abstract][Full Text] [Related]
14. Snake venom derived molecules in tumor angiogenesis and its application in cancer therapy; an overview.
Dhananjaya BL; Sivashankari PR
Curr Top Med Chem; 2015; 15(7):649-57. PubMed ID: 25714377
[TBL] [Abstract][Full Text] [Related]
15. [Snake Venom L-Amino Acid Oxidases potential biomedical applications].
Abdelkafi-Koubaa Z; Morjen M; Srairi-Abid N; El Ayeb M; Marrakchi N
Arch Inst Pasteur Tunis; 2014; 91(1-4):15-32. PubMed ID: 26402967
[TBL] [Abstract][Full Text] [Related]
16. Snake venoms and the hemostatic system.
Markland FS
Toxicon; 1998 Dec; 36(12):1749-800. PubMed ID: 9839663
[TBL] [Abstract][Full Text] [Related]
17. An Update on Potential Molecular Mechanisms Underlying the Actions of Snake Venom L-amino Acid Oxidases (LAAOs).
Paloschi MV; Pontes AS; Soares AM; Zuliani JP
Curr Med Chem; 2018; 25(21):2520-2530. PubMed ID: 29119915
[TBL] [Abstract][Full Text] [Related]
18. Antitumoral Potential of Snake Venom Phospholipases A2 and Synthetic Peptides.
Sobrinho JC; Simões-Silva R; Holanda RJ; Alfonso J; Gomez AF; Zanchi FB; Moreira-Dill LS; Grabner AN; Zuliani JP; Calderon LA; Soares AM
Curr Pharm Biotechnol; 2016; 17(14):1201-1212. PubMed ID: 27604356
[TBL] [Abstract][Full Text] [Related]
19. Protein Profile Analysis of Two Australian Snake Venoms by One- Dimensional Gel Electrophoresis and MS/MS Experiments.
Georgieva D; Hildebrand D; Simas R; Coronado MA; Kwiatkowski M; Schlüter H; Arni R; Spencer P; Betzel C
Curr Med Chem; 2017; 24(17):1892-1908. PubMed ID: 28571558
[TBL] [Abstract][Full Text] [Related]
20. Antitumoral potential of Tunisian snake venoms secreted phospholipases A2.
Zouari-Kessentini R; Srairi-Abid N; Bazaa A; El Ayeb M; Luis J; Marrakchi N
Biomed Res Int; 2013; 2013():391389. PubMed ID: 23509718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
